Table 1.
Patient Characteristics
| Groups | |||
|---|---|---|---|
| A(n=60) | B (n=60) | C (n=60) | |
| Sex(F) | 38(63.3) | 36(60.0) | 42(70.0) |
| Age(yr) | 53.3±9.1 | 49.7±10.7 | 48.4±12.9 |
| Weight (kg) | 65.2±10.4 | 62.9±8.9 | 62.5±12.5 |
| Height (m) | 1.63±0.07 | 1.63±0.07 | 1.63±0.09 |
| BMI(kg/m2) | 24.4±3.1 | 23.7±2.4 | 23.5±3.5 |
| ASA | |||
| I | 41(68.3) | 43(71.7) | 37(61.7) |
| II | 19(31.7) | 17(28.3) | 23(38.3) |
| Time from propofol administration to intubation (s) |
140.2±14.4* | 142.6±13.2# | 132.5±10.7 |
| Type of surgery | |||
| Abdominal | 12 | 10 | 15 |
| Breast | 18 | 21 | 18 |
| Urological | 11 | 13 | 9 |
| Gynecological | 19 | 16 | 18 |
Notes: mean (SD), median (interquartile range), or n (%), as appropriate, *P=0.0037 vs Group C; #P <0.0001 vs Group C; Group A, dexmedetomidine 0.6μg/kg; Group B, dexmedetomidine 0.8μg/kg; Group C, dexmedetomidine 1.0μg/kg.